C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients
Interdisciplinary Perspectives on Infectious Diseases · 29.04.2021 · 2021 · 1-5
DOI: 10.1155/2021/5557582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary Perspectives on Infectious Diseases, erschienen am 29.04.2021. Verfasst von Mahmoud Sadeghi-Haddad-Zavareh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
While some biomolecules have been explored to identify potential biomarkers for the prognosis of COVID-19 patients, there is no reliable prognostic indicator of the disease progression and severity. We aimed to evaluate the ability of the C-reactive protein (CRP) to predict COVID-19 infection outcome. This retrospective study was conducted on 429 patients diagnosed with COVID-19 between March 30, 2020, and April 30, 2020. The study population was divided into severe (n = 175) and nonsevere cases (n = 254). Data on demographic characteristics, clinical features, and laboratory findings on admission were collected. The proportion of patients with increased CRP levels was significantly higher in severe cases than in nonsevere patients. Analysis of the receiver operating characteristic (ROC) curve found that CRP could be used as an independent factor in predicting the severity of COVID-19. Also, patients with CRP >64.75 mg/L were more likely to have severe complications. In conclusion, CRP serum levels can predict the severity and progression of illness in patients with COVID-19.
Autor:innen und Institutionen
- Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
- Department of Radiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
- Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran.
- Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
- Department of Pathology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
ORCID-Profile: Mahmoud Sadeghi-Haddad-Zavareh, Masomeh Bayani, Mehran Shokri, Soheil Ebrahimpour, Arefeh Babazadeh, Rahele Mehraeen, Emadoddin Moudi, Ali Rostami, Mohammad Barary, Akram Hosseini, Ali Bijani, Mostafa Javanian
Zitieren
APA
Sadeghi-Haddad-Zavareh, M., Bayani, M., Shokri, M., Ebrahimpour, S., Babazadeh, A., Mehraeen, R., Moudi, E., Rostami, A., Barary, M., Hosseini, A., Bijani, A., & Javanian, M. (2021). C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdisciplinary Perspectives on Infectious Diseases, 2021, 1-5. https://doi.org/10.1155/2021/5557582
Vancouver
Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, et al. C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdisciplinary Perspectives on Infectious Diseases. 2021;2021:1-5. doi:10.1155/2021/5557582
BibTeX
@article{SadeghiHaddadZavareh2021,
author = {Sadeghi-Haddad-Zavareh, Mahmoud and Bayani, Masomeh and Shokri, Mehran and Ebrahimpour, Soheil and Babazadeh, Arefeh and Mehraeen, Rahele and Moudi, Emadoddin and Rostami, Ali and Barary, Mohammad and Hosseini, Akram and Bijani, Ali and Javanian, Mostafa},
title = {C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients},
journal = {Interdisciplinary Perspectives on Infectious Diseases},
year = {2021},
volume = {2021},
pages = {1--5},
doi = {10.1155/2021/5557582}
}
EUVIMED